Chemical and Pharmaceutical Bulletin p. 1858 - 1864 (1996)
Update date:2022-08-05
Topics:
Take, Kazuhiko
Okumura, Kazuo
Tsubaki, Kazunori
Taniguchi, Kiyoshi
Terai, Takao
Shiokawa, Youichi
N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine ((±)-3) was designed to restrict the conformation of terodiline I and was synthesized in a 6-step approach starting with diphenylacetaldehyde (10) or in a 4-step approach starting with 2,2-diphenyl-4-pentenoi
View MoreShanghai Hanhong Scientific Co.,Ltd.
website:http://www.chemvia.com
Contact:+86-21-64541543,54280654,13918533501
Address:Jiachuan Road 245
Contact:+86-574- 87178138; 87297407
Address:No. 809, Liudingxingzuo, cangsong road, Ningbo, China
Shandong Yuanli Science and Technology Co., Ltd.
Contact:86-0536-6777557
Address:Zhuliu Industiral Park,Changle County
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
zhejiang huangyan wanfeng pharm chem co.ltd
Contact:+86-576- 84160728
Address:No. 5 Dazha Road, Economic,Development Zone(JiangKou), Zhejiang, China
Doi:10.1039/a806200e
(1998)Doi:10.1021/jo00926a009
(1974)Doi:10.1021/jo00926a028
(1974)Doi:10.1246/bcsj.50.3417
(1977)Doi:10.1021/jo00322a047
(1981)Doi:10.1016/S0022-328X(00)86537-7
(1973)
